Glp1r Mm_00445292_m1
Staying patient and trusting the process is keysustainable weight loss takes time, and the gradual approach of semaglutide helps ensure long-term success
Novo plans to begin selling its FDA-approved weight-loss pill in the US in January following Oasis 4 trial results showing 13.6% average weight loss over 64 weeks, while Lilly's oral alternative, orforglipron, received expedited FDA review under a new 2025 voucher program and could be approved as soon as March, according to CEO Dave Ricks
GoodRx makes FDA-approved weight loss meds affordable and easy with online consults, pickup or delivery
Wan J, Ferrari C, Tadros M
Safety, Side Effects, and What to Expect GLP-1 medications are generally well-tolerated, with the most common side effects being mild nausea, slight appetite reduction (the intended effect), and occasional constipation during the first few weeks